INSIGHTS & NEWS

A company called Life Biosciences has just dosed the first human patient in a trial designed to reverse damage to the optic nerve, not slow it, reverse it.

 Soon, humanoid robots will work in homes and businesses. I first learned about this at a conference in Boston. Recently, I attended the Abundance Conference in early March. We spent an entire day discussing various robots.

As most of you know, Cosmo spends a good deal of time researching technology
and longevity. The attached article does a great job explaining Cosmo’s approach
to financial planning for longevity. Enjoy!

A few weeks ago, I had the pleasure of attending a five-day longevity conference in Boston. It was a fascinating event teeming with vendors offering longevity products and featuring presentations from medical doctors.

In a recent edition of Cosmo’s Corner, I delved into the fascinating world of robots and their potential to assist us in our homes.

Here’s a comprehensive look at humanoid and other robots in our homes and hospitals, the tasks they perform, and how they’re making life better today — as well as what’s just over the horizon.

Managing Partner To Engage With Leading Scientists and Innovators Advancing Breakthroughs in Health, Aging, and Financial Planning

The 680 Group is pleased to announce the addition of Robin Mellie as Director, further expanding the firm’s commitment to compassionate, personalized financial planning.

Humanoid robots are quickly progressing from research labs to real-world deployment, and their entry into the consumer market is expected within the next 2–5 years.

The 680 Group, a leading wealth management office based in Atlanta, is proud to announce its recognition by Independent Advisor Alliance with inclusion in the prestigious Chairman level status.